Report : Asia Pacific Skin Grafting System Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Dermatomes, Wound Debridement Devices, Skin Graft Mesher Equipment and Accessories, and Others), Type (Autograft and Allograft), Wound Type (Burns, Chronic Wounds, Surgical Wounds, Traumatic Wounds, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Specialty Clinics)
Autograft Segment to Dominate APAC Skin Grafting System Market during 2020–2028
According to a new market research study on “APAC Skin Grafting System Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Type, Wound Type, and End User” is expected to reach US$ 252.70 million by 2028 from 152.62 US$ million in 2021. The market is estimated to grow at a CAGR of 7.5% from 2021 to 2028. The report provides trends prevailing in the APAC skin grafting system market along with the drivers and restraints pertaining to the market growth. Increasing variety of skin graft sources for grafting systems is the major factor driving the growth of the APAC skin grafting system market. However, issues associated with high cost of skin grafting procedures hinders the growth of APAC skin grafting system market.
The APAC skin grafting system market is segmented on the basis of product type, type, wound type, end user, and country. The market, based on product type, is segmented into dermatomes, wound debridement devices, skin graft mesher equipment and accessories, and others. The wound debridement devices segment held the largest share of the market in 2021. Based on type, the APAC skin grafting system market is bifurcated into autograft and allograft. The autograft segment held a larger share of the market in 2021 and is expected to hold a significant share of the market during the forecast period. Based on wound type, the market is segmented into burns, chronic wounds, traumatic wounds, surgical wounds, and others. The burns segment is expected to hold the largest market share during the forecast period. Based on end user, the APAC skin grafting system market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held the largest share of the market and is expected to register the highest CAGR during the forecast period. Based on country, the APAC skin grafting system market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC.
Aygun Surgical Instruments Co., Inc.; De Soutter Medical; Humeca BV; Integra Lifesciences Holdings Corp.; Lutz GmbH & Co. KG; Smith & Nephew; Stryker Corp.; and Zimmer Biomet are among the leading companies in the APAC skin grafting system market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Integra LifeSciences completed the acquisition of ACell, Inc. to expand its skin grafting and wound management solutions.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: firstname.lastname@example.org